Skip to content

Arjun Agarwal, Senior Vice President, Finance at Oruka Therapeutics, sold ORKA on Sep 15, 2026

Data as of Oct 16

▼ SELL$53.6K560 shares at $95.71Arjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.
Watch ORKA
Traded
Sep 15, 2026
Disclosed
Sep 15, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Arjun Agarwal, Senior Vice President, Finance at Oruka Therapeutics, sold ORKA on Sep 15, 2026TRADEDDISCLOSED
ORKASimilar stocks (XLV — its sector index fund), rebased to ORKA's price on the disclosure day
ORKA since disclosure
−22.0%
after the sale
Similar stocks (XLV) since disclosure
+5.4%
XLV — its sector index fund

Change in closing price from Sep 15, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$18.8Kdisclosed Sep 15 · filed 4 days after the trade
  2. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$374Kdisclosed Sep 15 · filed 4 days after the trade
  3. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$206Kdisclosed Sep 15 · filed 4 days after the trade
  4. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$273Kdisclosed Sep 15 · filed 4 days after the trade

See every trade on ORKA →